Loss of insulin-like growth factor-II imprinting and the presence of screen-detected colorectal adenomas in women

Journal of the National Cancer Institute

Volumn 96, Issue 5, 2004, Pages 407-410

  Woodson, Karen ^a   Flood, Andrew ^b   Green, Lisa ^a   Tangrea, Joseph A ^a   Hanson, Jeffrey ^a   Cash, Brooks ^c   Schatzkin, Arthur ^a   Schoenfeld, Phillip ^d,e  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c WALTER REED ARMY MEDICAL CENTER   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN B; ACTIN; COMPLEMENTARY DNA;

ADENOMA; ADULT; ARTICLE; BODY MASS; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CLINICAL ARTICLE; COLON MUCOSA; COLONOSCOPY; COLORECTAL CANCER; COLORECTAL TUMOR; CONFIDENCE INTERVAL; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC TRAIT; HUMAN; HYPOTHESIS; PRIORITY JOURNAL; RISK ASSESSMENT; TUMOR DIAGNOSIS; AGED; COLON; DNA METHYLATION; GENE EXPRESSION REGULATION; GENETICS; GENOME IMPRINTING; INCIDENCE; INTESTINE MUCOSA; MASS SCREENING; METABOLISM; METHODOLOGY; MIDDLE AGED; RISK; UPREGULATION;

ACTINS; ADENOMA; ADULT; AGED; COLON; COLONOSCOPY; COLORECTAL NEOPLASMS; DNA METHYLATION; DNA, COMPLEMENTARY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOMIC IMPRINTING; HUMANS; INCIDENCE; INSULIN-LIKE GROWTH FACTOR II; INTESTINAL MUCOSA; MASS SCREENING; MIDDLE AGED; ODDS RATIO; RISK ASSESSMENT; UP-REGULATION;

EID: 1542318319     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/djh042     Document Type: Article

References (14)

1. Pfeifer K. Mechanisms of genomic imprinting. Am J Hum Genet 2000;67:777-87.
2. Ferguson-Smith AC, Surani MA. Imprinting and the epigenetic asymmetry between parental genomes. Science 2001;293:1086-9.
3. Reik W, Walter J. Genomic imprinting: Parental influence on the genome. Nat Rev Genet 2001;2:21-32.
4. Cui H, Onyango P, Brandenburg S, Wu Y, Hsieh CL, Feinberg AP. Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2. Cancer Res 2002;62: 6442-6.
5. Nakagawa H, Chadwick RB, Peltomaki P, Plass C, Nakamura Y, de La Chapelle A. Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer. Proc Natl Acad Sci U S A 2001;98:591-6.
6. Cui H, Horon IL, Ohlsson R, Hamilton SR, Feinberg AP. Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Nat Med 1998;4: 1276-80.
7. Cui H, Cruz-Correa M, Giardiello FM, Hutcheon DF, Kafonek DR, Brandenburg S, et al. Loss of IGF2 imprinting: A potential marker of colorectal cancer risk. Science 2003;299:1753-5.
8. Sakatani T, Wei M, Katoh M, Okita C, Wada D. Mitsuya K, et al. Epigenetic heterogeneity ar imprinted loci in normal populations. Biochem Biophys Res Commun 2001;283:1124-30.
9. Tycko B. Genomic imprinting and cancer. Results Probl Cell Differ 1999;25:133-69.
10. Kohda M, Hoshiya H, Katoh M, Tanaka I, Masuda R, Takemura T, et al. Frequent loss of imprinting of IGF2 and MEST in lung adenocarcinoma. Mol Carcinog 2001;31:184-91.
11. Pedersen IS, Dervan PA, Broderick D, Harrison M, Miller N, Delany E, et al. Frequent loss of imprinting of PEG1/MEST in invasive breast cancer. Cancer Res 1999;59: 5449-51.
12. Cai YC, Yang GY, Nie Y, Wang LD, Zhao X, Song YL, et al. Molecular alterations of p73 in human esophageal squamous cell carcinomas: Loss of heterozygosity occurs frequently; loss of imprinting and elevation of p73 expression may be related to defective p53. Carcinogenesis 2000;21:683-9.
13. Ravenel JD, Broman KW, Perlman EJ, Niemitz EL, Jayawardena TM, Bell DW, et al. Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumor. J Natl Cancer Inst 2001;93: 1698-703.
14. Wang WH, Duan JX, Vu TH, Hoffman AR. Increased expression of the insulin-like growth factor-II gene in Wilms' tumor is not dependent on loss of genomic imprinting or loss of heterozygosity. J Biol Chem 1996; 271: 27863-70.